Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCS.L Regulatory News (MCS)

  • There is currently no data for MCS

Directorate Change

12 May 2020 07:00

RNS Number : 5523M
McCarthy & Stone PLC
12 May 2020
 

 

12 May 2020

 

McCarthy & Stone plc

 

Directorate Change

 

 

McCarthy & Stone plc (the 'Company'), the UK's leading developer and manager of retirement communities, in compliance with Listing Rule 9.6.11 (1)(2), today announces that Rowan Baker, Chief Financial Officer (CFO), has informed the Board of her intention to step down as CFO and as a Director of the Company to become CFO of Laing O'Rourke.

 

The Board is pleased to confirm that Martin Abell will join the business as CFO Designate on 26 May 2020, becoming CFO on 1 August 2020, following Rowan's departure. Martin most recently held the position of CFO at Clinigen Group plc, the pharmaceutical and services company, and prior to that was the Finance Director (Europe and Rest of World division) for Hays plc, the FTSE 250 professional recruitment company.

 

Rowan will remain with the business to provide a smooth handover with Martin and the wider finance team. Her departure date will be 31 July 2020, following the Group's HY20 Results on 15 July 2020.

 

Rowan joined McCarthy & Stone in 2012 and was appointed to the Board in January 2017. She played a key role in the Company's IPO and in developing and delivering the Company's new strategy, as well as driving several transformation initiatives.

 

John Tonkiss, Chief Executive Officer, said: "On behalf of the Board, I would like to thank Rowan for her huge contribution over the past eight years. Personally, I am extremely grateful for her guidance and support, particularly since she took on the role as CFO, and we wish her the very best with her new position. I am also pleased to welcome Martin to the Company. His commercial and public company experience will be of huge benefit and I look forward to working with him."

 

The Company confirms that there is no further information to be disclosed pursuant to paragraph LR 9.6.13R of the Listing Rules of the Financial Conduct Authority with regard to the appointment of Martin Abell.

 

- Ends -

 

For more information, please contact:

 

Adam Batty, Group General Counsel and Company Secretary

07976 666608

 

Marina Calero, Investor Relations Director

07770956122

 

Powerscourt, 020 7250 1446 / mccarthy-stone@powerscourt-group.com

Justin Griffiths

Nick Dibden

Victoria Heslop

 

Notes to Editors

McCarthy & Stone is the UK's leading developer and manager of retirement communities, with a significant market share. The Group buys land and then builds, sells and manages high-quality retirement developments. It has built and sold more than 58,000 properties across more than 1,300 retirement developments since 1977 and is renowned for its focus on the needs of those in later life.

McCarthy & Stone has two main product ranges - Retirement Living and Retirement Living PLUS - which provide mainly one and two-bedroom apartments across the country with varying levels of support and care for older people. Retirement Living developments provide independence in private apartments designed specifically for the over-60s, as well as facilities such as communal lounges and guest suites that support companionship. Retirement Living PLUS developments, which are designed specifically for the over-70s, offer all of this plus more on-site facilities such as restaurants, well-being suites and function rooms. Importantly, they also provide on-site flexible care and support packages to assist those needing additional help. 

All developments built since 2010 are managed by the company's in-house management services team, providing peace of mind that it will look after customers and their properties over the long term. This is a key part of how McCarthy & Stone seeks to enrich its customers' lives. This commitment to quality and customer service continues to be recognised by residents. In March 2020, the Group again received the full five star rating for customer satisfaction from the Home Builders Federation - making it the only UK developer, of any size or type, to achieve this accolade for 15 consecutive years.

For further information, please visit www.mccarthyandstone.co.uk

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAGPUPAAUPUGQG
Date   Source Headline
31st Jul 20208:23 amRNSDirectorate Change
29th Jul 20205:41 pmRNSHolding(s) in Company
15th Jul 20207:01 amRNSDirectorate Change
15th Jul 20207:00 amRNSHalf Year Results
3rd Jul 20209:00 amRNSNotice of Interim Results
22nd Jun 20204:11 pmRNSHolding(s) in Company
9th Jun 20204:18 pmRNSHolding(s) in Company
2nd Jun 20207:00 amRNSCOVID-19 Business Update
1st Jun 20209:30 amRNSDirector/PDMR Shareholding
28th May 202012:13 pmRNSDirector/PDMR Shareholding
19th May 20201:11 pmRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSDirectorate Change
1st May 20207:00 amRNSTotal Voting Rights
1st May 20207:00 amRNSHolding(s) in Company
30th Apr 20205:56 pmRNSSale of assets to Waverstone LLP
29th Apr 20203:50 pmRNSDisclosure of Rights Attached to Equity Shares
7th Apr 202011:41 amRNSAdditional Listing
2nd Apr 20204:28 pmRNSDirector/PDMR Shareholding
27th Mar 20202:37 pmRNSHolding(s) in Company
25th Mar 202011:14 amRNSResults of Annual General Meeting
25th Mar 20207:00 amRNSAGM & Business Update
24th Mar 20201:37 pmRNSHolding(s) in Company
20th Mar 20204:17 pmRNSAnnual General Meeting and Covid-19
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 202010:56 amRNSCOVID-19 update
12th Mar 202011:44 amRNSHolding(s) in Company
2nd Mar 20209:14 amRNSTotal Voting Rights
19th Feb 202010:03 amRNSAnnual Financial Report
11th Feb 202010:22 amRNSDirector/PDMR Shareholding
7th Feb 20208:32 amRNSDirector/PDMR Shareholding
3rd Feb 20201:50 pmRNSHolding(s) in Company
3rd Feb 20209:16 amRNSBlock listing Interim Review
3rd Feb 20209:04 amRNSTotal Voting Rights
29th Jan 20203:45 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSFull Year Results
15th Jan 202010:40 amRNSDirector Declaration
13th Jan 20207:00 amRNSNotice of Results
10th Jan 20207:00 amRNSAppointment - General Counsel & Company Secretary
9th Jan 20202:35 pmRNSHolding(s) in Company
2nd Jan 202010:30 amRNSTotal Voting Rights
12th Dec 20199:12 amRNSDirectorate Change
15th Nov 20198:55 amRNSDirector/PDMR Shareholding
14th Nov 20198:06 amRNSHolding(s) in Company
13th Nov 20193:09 pmRNSHolding(s) in Company
7th Nov 20199:09 amRNSHolding(s) in Company
7th Nov 20197:00 amRNSFY19 Trading Update
1st Nov 20198:27 amRNSDirectorate Change
24th Oct 20198:05 amRNSHolding(s) in Company
22nd Oct 20193:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.